MEDIPOSTCO.,LTD.: debt-to-equity, ROE and more
KOSDAQ, Legal name MEDIPOSTCO.,LTD.
Latest figures are the FY2025 consolidated summary statements.
Latest fiscal year ratios (computed here)
- Debt/equity
- 72.7%
- Equity ratio
- 57.9%
- ROE
- -34.4%
- Op. margin
- -92.3%
- Rev. growth
- 4.2%
- Interest coverage
- n/a
Condition flags
- Latest operating profit is not above zero, or not reported.
- Operating loss for 5 straight years.
- Total equity is above paid-in capital. Not capital-impaired.
Interest coverage and dividends (OpenDART)
Interest expense and dividends come from DART's OpenDART annual-report filings, not the FSC summary statements used above. The source differs from the other tables on this page.
Interest coverage = operating profit ÷ interest expenseNo interest expense value yet for this company. Most companies fold interest expense into a single finance-costs line on their income statement, so it cannot be pulled out separately. Interest coverage is not computed here.
Dividends, last 3 fiscal years
No dividend data yet for this company.
Source values from the OpenDART (금융감독원 전자공시) annual report. Report fiscal year 2025.
Ratios by year (computed here)
Debt-to-equity = total liabilities ÷ total equity × 100Equity ratio = total equity ÷ total assets × 100ROE = net income ÷ year-end total equity × 100Operating margin = operating profit ÷ revenue × 100Revenue growth = (this year − last year) ÷ last year × 100
Computed from the source figures above with these formulas. Where the source's own debt-to-equity differs from ours, both are shown for that year.
| Fiscal year | Debt/equity | Equity ratio | ROE | Op. margin | Rev. growth |
|---|---|---|---|---|---|
| FY2021 consolidated | 56.7% | 63.8% | -0.6% | -9.5% | n/a |
| FY2022 consolidated | 117.9% | 45.9% | 1.2% | -27.1% | 17.0% |
| FY2023 consolidated | 43.3% | 69.8% | 1.6% | -36.6% | 6.9% |
| FY2024 consolidated | 64.0% | 61.0% | -25.1% | -68.7% | 2.9% |
| FY2025 consolidated | 72.7% | 57.9% | -34.4% | -92.3% | 4.2% |
Source figures (FSC summary statements)
Amounts are the source values, shortened. A cell reported as zero may be blank in the source, so it is not used in any ratio.
| Fiscal year | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | ₩54.9B | ₩64.2B | ₩68.6B | ₩70.7B | ₩73.7B |
| Operating profit | -₩5.2B | -₩17.4B | -₩25.1B | -₩48.5B | -₩68.0B |
| Pre-tax income | ₩602.4M | ₩6.5B | ₩4.4B | -₩62.9B | -₩85.9B |
| Net income | -₩966.4M | ₩2.1B | ₩5.0B | -₩63.4B | -₩86.0B |
| Total assets | ₩254.1B | ₩397.8B | ₩449.4B | ₩414.3B | ₩431.6B |
| Total liabilities | ₩91.9B | ₩215.2B | ₩135.7B | ₩161.7B | ₩181.6B |
| Total equity | ₩162.2B | ₩182.6B | ₩313.7B | ₩252.6B | ₩249.9B |
| Paid-in capital | ₩8.1B | ₩8.1B | ₩17.1B | ₩17.1B | ₩19.6B |
| Debt/equity (source value) | 56.7% | 117.9% | 43.3% | 64.0% | 72.7% |
Company outline (FSC)
- Market
- KOSDAQ
- Fiscal year end
- Dec
- Founded
- 2000-06-26
- Listed
- 05/07/29
- Employees
- 342
- Auditor
- 한울회계법인
- Audit opinion
- 적정의견
- Corporate reg. no.
- 1101112007709
- Outline updated
- 2026-09-24
Check the original filings
Read the annual report and audit report before you decide anything. The link opens a DART search for this company's name.
Search DART for 메디포스트Computed from the Financial Services Commission's company outline and summary statements (data.go.kr). Data as of 2026-09-24.